HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Clinical trials for HIGH-GRADE B-CELL LYMPHOMA (HGBCL) explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE B-CELL LYMPHOMA (HGBCL) trials appear
Sign up with your email to follow new studies for HIGH-GRADE B-CELL LYMPHOMA (HGBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR-T therapy aims to control Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a new treatment called Talikabtagene autoleucel (NexCAR19) for adults with certain blood cancers that have come back or not responded to standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to better recognize and attack …
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Phase: PHASE2, PHASE3 • Sponsor: Health Institutes of Turkey • Aim: Disease control
Last updated May 26, 2026 03:07 UTC
-
New CAR T-Cell therapy targets tough blood cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called GF-CART01 for adults aged 18-70 with B-cell blood cancers (like certain lymphomas) that have come back or not responded to standard treatments. The therapy uses a patient's own immune cells, modified to target two markers (CD20 …
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Phase: PHASE1 • Sponsor: GenomeFrontier Therapeutics TW Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
Last-Resort hope: new drug offered to lymphoma patients with no options left
Disease control AVAILABLEThis program gives people with certain types of lymphoma (like follicular lymphoma or diffuse large B-cell lymphoma) who have tried all other treatments access to an experimental drug called odronextamab. The goal is to provide a possible treatment option when no others are avail…
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 07, 2026 18:39 UTC